OmniStar Financial Group’s Idexx Laboratories IDXX Stock Holding History

OmniStar Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,610	Closed	-$402K	–	118
2018 Q3	$402K	Sell	1,610 -140	-8%	-$34K	0.31%	104
2018 Q2	$381K	Buy	1,750 +85	+5%	+$17.5K	0.36%	74
2018 Q1	$323K	Sell	1,665 -775	-32%	-$143K	0.31%	81
2017 Q4	$382K	Buy	+2,440	New	+$384K	0.35%	74

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OmniStar Financial Group's IDXX Position: Q4 2018 in Review

OmniStar Financial Group sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 1,610 shares — an estimated $402K sold.

OmniStar Financial Group first reported a position in IDXX in Q4 2017 and held it in 4 quarters. The position peaked at $402K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

OmniStar Financial Group reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
OmniStar Financial Group sold 1,610 Idexx Laboratories shares in Q4 2018, an estimated $402K.
OmniStar Financial Group first reported a position in Idexx Laboratories in Q4 2017 and held it in 4 quarters.
OmniStar Financial Group's Idexx Laboratories position peaked at $402K in Q3 2018.
670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on OmniStar Financial Group's 13F filing for Q4 2018, filed 12 Feb 2019.